ESR1 and breast carcinoma: Since TNBC does not express the estrogen receptor, the progesterone receptor, and the human epidermal growth factor receptor 2, limited, targeted specific agents are available for the treatment of TNBC, which is usually managed by conventional approaches, such as surgery, chemo and radiotherapy, resulting in a high rate of breast cancer recurrence [1].